Mohammad Bahmanyar

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The aim of this study is to assess nucleoprotein expression of IKZF1/3 in patients with relapsed/refractory multiple myeloma (MM) who received lenalidomide-based therapy and correlated them with their clinical outcomes. A total of 50 patients diagnosed with MM were entered in the study with the median follow-up of 86.4 months. By immunohistochemistry (IHC),(More)
  • 1